LncRNAs AC091878.1 and RP11-108L7.15 identified as protective factors in the m5C LPS were found to be significantly higher in WHO Grade II tumors while LINC00632 and PAXIP.AS1 presented significantly higher expression in WHO Grade III gliomas. Here, LINC00632 is linked to glioma.